Whole clotting assessment as predictor of clinical phenotype in patients with severe haemophilia A

Whole clotting assessment as predictor of clinical phenotype in patients with severe haemophilia A - HAEMOTYPE study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON35637

Enrollment

Registered

2011-11-14

Start date

2011-12-23

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

haemophilia

Interventions

None listed

Eligibility

Age

2 Years to 99 Years

Inclusion criteria

Inclusion criteria: male patients with severe haemophilia A (FVIII

Exclusion criteria

Exclusion criteria: patient with inhibitor in the past administration FVIII concentrate

Design outcomes

Primary

Measure	Time frame
Clinical parameters: age of first bleeding, clinical bleeding score Laboratory parameters: whole clotting assessment parameters (TM-ETP/ETP: lag time, peak thrombin, area under the curve. T-TAS: time to occlusion, occlusion time, occlusion speed, area under the curve)	—

Countries

Netherlands

Outcome results